| Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled … JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ... MedRxiv, 2020 | 178 | 2020 |
| Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ... The Lancet Rheumatology 2 (11), e698-e711, 2020 | 126 | 2020 |
| Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID‐19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient … E Burn, X Li, K Kostka, HM Stewart, C Reich, S Seager, T Duarte‐Salles, ... Pharmacoepidemiology and Drug Safety 31 (5), 495-510, 2022 | 41 | 2022 |
| Comparative effectiveness and safety between apixaban, dabigatran, edoxaban, and rivaroxaban among patients with atrial fibrillation: a multinational population-based cohort study WCY Lau, CO Torre, KKC Man, HM Stewart, S Seager, M Van Zandt, ... Annals of Internal Medicine 175 (11), 1515-1524, 2022 | 31 | 2022 |
| Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS K Kostka, T Duarte-Salles, A Prats-Uribe, AG Sena, A Pistillo, S Khalid, ... Clinical Epidemiology, 369-384, 2022 | 27 | 2022 |
| OHDSI-COVID-19 consortium. Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ... Lancet Rheumatol 2 (11), e698-e711, 2020 | 13 | 2020 |
| OPMI: the Ontology of Precision Medicine and Investigation and its Support for Clinical Data and Metadata Representation and Analysis. Y He, E Ong, J Schaub, F Dowd, JF O'Toole, A Siapos, CG Reich, ... ICBO, 1-10, 2019 | 12 | 2019 |
| Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM R Khera, LS Dhingra, A Aminorroaya, K Li, JJ Zhou, F Arshad, C Blacketer, ... BMJ medicine 2 (1), 2023 | 6 | 2023 |
| Clinical characterization of patients diagnosed with prostate cancer and undergoing conservative management: a PIONEER analysis based on big data G Gandaglia, F Pellegrino, A Golozar, B De Meulder, T Abbott, A Achtman, ... European Urology 85 (5), 457-465, 2024 | 5 | 2024 |
| Risk of COVID-19 diagnosis and hospitalisation in patients with osteoarthritis or back pain treated with ibuprofen compared to other NSAIDs or paracetamol: a network cohort study J Xie, JT Brash, C Turkmen, S Driessen, G Varrassi, G Argyriou, S Seager, ... Drugs 83 (3), 249-263, 2023 | 5 | 2023 |
| Ranitidine Use and Incident Cancer in a Multinational Cohort SC You, SI Seo, T Falconer, C Yanover, T Duarte-Salles, S Seager, ... JAMA network open 6 (9), e2333495-e2333495, 2023 | 1 | 2023 |
| Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS (preprint) D Prieto-Alhambra, K Kostka, T Duarte-Salles, A Prats-Uribe, A Sena, ... | 1 | 2021 |
| Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States V Lo Re III, NM Cocoros, RA Hubbard, SK Dutcher, CW Newcomb, ... Clinical Epidemiology, 71-89, 2024 | | 2024 |
| Characteristics and Outcomes for Recipients of NVX-CoV2373: A Real-World Retrospective Study in Germany L Kutikova, JT Brash, K Helme, J Brewster, M Brand, A Adam, S Seager, ... Vaccines 12 (4), 387, 2024 | | 2024 |
| Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM Study R Khera, A Aminorroaya, LS Dhingra, PM Thangaraj, AP Camargos, F Bu, ... medRxiv, 2024.02. 05.24302354, 2024 | | 2024 |
| Calculating daily dose in the observational medical outcomes partnership (OMOP) common data model T Burkard, K López-Güell, A Gorbachev, L Bellas, AM Jödicke, E Burn, ... Pharmacoepidemiology and Drug Safety, 2024 | | 2024 |
| Incidence of mental health diagnoses during the COVID-19 pandemic: a multinational network study Y Chai, KKC Man, H Luo, CO Torre, YK Wing, JF Hayes, DPJ Osborn, ... Epidemiology and Psychiatric Sciences 33, e9, 2024 | | 2024 |
| Survivorship data in Prostate Cancer: Where are we and where do we need to be? B Russell, K Beyer, A Lawlor, MJ Roobol, LDF Venderbos, S Remmers, ... European Urology Open Science 59, 27-29, 2024 | | 2024 |
| RWD103 NVX-CoV2373 Patient Characteristics in Germany: Real-World Retrospective Database Study Shows Most Vaccine Recipients Were Among the High Risk Category A Adam, K Helme, M Brand, J Brewster, S Seager, L Kutikova, K Kostev, ... Value in Health 26 (12), S524, 2023 | | 2023 |
| EPH161 Epidemiology Landscape and Impact of Obesity: Multi-Country Results from the Impact-O Study E Artime, E Spaepen, A Adam, X Lin, M Shang, S Seager, JE Mount, ... Value in Health 26 (12), S233, 2023 | | 2023 |
